To the best of our knowledge, this case–control study is the first of its kind, since it assessed the hepatokine profile of FGF21, selenoprotein P, fetuin A, and SHBG in adolescent PCOS patients. This evidence concerns the gene SHBG and polycystic ovary syndrome.